Breast Cancer Clinical Trial

Sexual Health and Rehabilitation After Ovarian Suppression Treatment

Summary

This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.

View Full Description

Full Description

The purpose of this research is to study the effectiveness of an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of cancer recurrence. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning.

- This study consists of attending a group educational session followed by a one-on-one telephone coaching session.

The group educational session will last about 4 hours, and will include information on resources, self-help strategies, and relaxation techniques.
The telephone coaching session will take place four weeks after the group session, and will last about 15 minutes

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women with a history of breast cancer who are currently on chemical ovarian suppression
Current age ≤ 50
No active cancer therapy in the past 6 months and no future therapy planned
Endorsement of at least one sexual symptom (see Appendix A for eligibility screening)
English-speaking

Exclusion Criteria:

History of pelvic radiation
Prior participation in one of Dr. Bober's sexual health workshops

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT03571841

Recruitment Status:

Completed

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02215, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT03571841

Recruitment Status:

Completed

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider